Search

Your search keyword '"Pinana, Jose Luis"' showing total 73 results
Start Over Author "Pinana, Jose Luis"

Refine your results

more »

more »

more »
73 results on '"Pinana, Jose Luis"'

1. Viral Infections

Author

Ljungman, Per, Piñana, Jose Luis, Cesaro, Simone, de la Cámara, Rafael, Sureda, Anna, editor, Corbacioglu, Selim, editor, Greco, Raffaella, editor, Kröger, Nicolaus, editor, and Carreras, Enric, editor

Published
2024
Full Text
View/download PDF

2. Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients: Recommendations from the EBMT practice harmonization and guidelines committee

Author

Piñana, José Luis, Cesaro, Simone, Mikulska, Malgorzata, Verweij, Paul E., Bergeron, Anne, Neofytos, Dionysios, Styczynski, Jan, Sánchez-Ortega, Isabel, Greco, Raffaella, Onida, Francesco, Yakoub-Agha, Ibrahim, Averbuch, Dina, Cámara, Rafael de la, and Ljungman, Per

Published
2024
Full Text
View/download PDF

3. EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome

Author

Hernani, Rafael, Aiko, Mika, Victorio, Ruth, Benzaquén, Ana, Pérez, Ariadna, Piñana, José Luis, Hernández-Boluda, Juan Carlos, Amat, Paula, Pastor-Galán, Irene, Remigia, María José, Ferrer-Lores, Blanca, Micó, Mireia, Carbonell, Nieves, Ferreres, José, Blasco-Cortés, María Luisa, Santonja, José Miguel, Dosdá, Rosa, Estellés, Rocío, Campos, Salvador, Martínez-Ciarpaglini, Carolina, Ferrández-Izquierdo, Antonio, Goterris, Rosa, Gómez, Montse, Teruel, Anabel, Saus, Ana, Ortiz, Alfonso, Morello, Daniela, Martí, Edel, Carretero, Carlos, Calabuig, Marisa, Tormo, Mar, Terol, María José, Cases, Paula, and Solano, Carlos

Published
2024
Full Text
View/download PDF

5. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil

Author

Esquirol, Albert, Pascual, Maria Jesus, Montoro, Juan, Piñana, José Luis, Ferrà, Christelle, Herruzo, Beatriz, Garcia-Cadenas, Irene, Balaguer, Aitana, Perez, Ariadna, Huguet, Maria, Redondo, Sara, Villalba, Marta, Hernandez-Boluda, Juan Carlos, Chorao, Pedro, Hernani, Rafael, Sanz, Jaime, Solano, Carlos, Sierra, Jorge, and Martino, Rodrigo

Published
2024
Full Text
View/download PDF

7. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model

Author

Hernández-Boluda, Juan-Carlos, Pereira, Arturo, Alvarez-Larran, Alberto, Martín, Ana-Africa, Benzaquen, Ana, Aguirre, Lourdes, Mora, Elvira, González, Pedro, Mora, Jorge, Dorado, Nieves, Sampol, Antonia, García-Gutiérrez, Valentín, López-Godino, Oriana, Fox, María-Laura, Reguera, Juan Luis, Pérez-Encinas, Manuel, Pascual, María-Jesús, Xicoy, Blanca, Parody, Rocío, González-Pinedo, Leslie, Español, Ignacio, Avendaño, Alejandro, Correa, Juan-Gonzalo, Vallejo, Carlos, Jurado, Manuel, García-Cadenas, Irene, Osorio, Santiago, Durán, María-Antonia, Sánchez-Guijo, Fermín, Cervantes, Francisco, and Piñana, José-Luis

Published
2020
Full Text
View/download PDF

8. Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score

Author

Berro, Mariano, Chhabra, Saurabh, Piñana, José Luis, Arbelbide, Jorge, Rivas, Maria M., Basquiera, Ana Lisa, Vitriu, Adriana, Requejo, Alejandro, Milovic, Vera, Yantorno, Sebastian, Bentolila, Gonzalo, Garcia, Juan Jose, Castro, Martin, Palmer, Silvina, Saslavsky, Martin, Duarte, Patricio, Cerutti, Amalia, Jarchum, Gustavo, Tisi Baña, Matias, Thapa, Bicky, Solano, Carlos, Sureda, Anna, Rovira, Montserrat, Shaw, Bronwen E, and Kusminsky, Gustavo

Published
2020
Full Text
View/download PDF

10. Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies

Author

Sanz, Jaime, Montoro, Juan, Solano, Carlos, Valcárcel, David, Sampol, Antonia, Ferrá, Christelle, Parody, Rocío, Lorenzo, Ignacio, Montesinos, Pau, Ortí, Guillermo, Hernández-Boluda, Juan C., Balaguer-Roselló, Aitana, Guerreiro, Manuel, Carretero, Carlos, Sanz, Guillermo F., Sanz, Miguel A., and Piñana, José Luis

Published
2020
Full Text
View/download PDF

13. Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Author

Guglieri-Lopez, Beatriz, Perez-Pitarch, Alejandro, Garcia-Cadenas, Irene, Gimenez, Estela, Barba, Pere, Rabella, Nuria, Hernandez-Boluda, Juan Carlos, Fox, Laura, Valcarcel, David, Esquirol, Albert, Ferriols-Lisart, Rafael, Sierra, Jorge, Solano, Carlos, Navarro, David, Martino, Rodrigo, and Piñana, José Luis

Published
2019
Full Text
View/download PDF

18. Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions

Author

Ortí, Guillermo, Sanz, Jaime, García-Cadenas, Irene, Sánchez-Ortega, Isabel, Alonso, Laura, Jiménez, Maria José, Sisinni, Luisa, Azqueta, Carmen, Salamero, Olga, Badell, Isabel, Ferra, Christelle, de Heredia, Cristina Diaz, Parody, Rocio, Sanz, Miguel Angel, Sierra, Jorge, Piñana, Jose Luis, Querol, Sergi, and Valcárcel, David

Published
2018
Full Text
View/download PDF

19. CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Author

Barba, Pere, Martino, Rodrigo, Zhou, Qin, Cho, Christina, Castro-Malaspina, Hugo, Devlin, Sean, Esquirol, Albert, Giralt, Sergio, Jakubowski, Ann A., Caballero, Dolores, Maloy, Molly, Papadopoulos, Esperanza B., Piñana, José Luís, Fox, María Laura, Márquez-Malaver, Francisco J., Valcárcel, David, Solano, Carlos, López-Corral, Lucía, Sierra, Jorge, and Perales, Miguel-Angel

Published
2018
Full Text
View/download PDF

22. A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis

Author

Piñana, José Luis, Perez-Pitarch, Alejandro, Garcia-cadenas, Irene, Barba, Pere, Hernandez-Boluda, Juan Carlos, Esquirol, Albert, Fox, María Laura, Terol, María José, Queraltó, Josep M., Vima, Jaume, Valcarcel, David, Ferriols-Lisart, Rafael, Sierra, Jorge, Solano, Carlos, and Martino, Rodrigo

Published
2017
Full Text
View/download PDF

23. Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen–Matched Sibling Transplantation

Author

Balaguer Rosello, Aitana, Bataller, Luis, Lorenzo, Ignacio, Jarque, Isidro, Salavert, Miguel, González, Eva, Piñana, José Luis, Sevilla, Teresa, Montesinos, Pau, Iacoboni, Gloria, Muelas, Nuria, Romero, Samuel, Carretero, Carlos, Montoro, Juan, Ibáñez-Juliá, Maria Jose, Sanz, Guillermo, Sanz, Miguel Ángel, and Sanz, Jaime

Published
2017
Full Text
View/download PDF

24. Central Nervous System Involvement in Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation

Author

Balaguer-Rosello, Aitana, Piñana, José Luis, Bataller, Luis, Montoro, Juan, Romero, Samuel, Navarro, Irene, Lorenzo, Ignacio, Andreu, Rafael, Guerreiro, Manuel, Aguilar, Cristobal, Gorriz, David, Dominguez, Lara, de la Puerta, Rosalia, Gómez, Inés, Solves, Pilar, Jarque, Isidro, Sanz, Miguel Ángel, Sanz, Guillermo, and Sanz, Jaime

Published
2021
Full Text
View/download PDF

25. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19 : An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Author

Ljungman, Per, Tridello, Gloria, Pinana, Jose Luis, Ciceri, Fabio, Sengeloev, Henrik, Kulagin, Alexander, Mielke, Stephan, Yegin, Zeynep Arzu, Collin, Matthew, Einardottir, Sigrun, Lepretre, Sophie Ducastelle, Maertens, Johan, Campos, Antonio, Metafuni, Elisabetta, Pichler, Herbert, Folber, Frantisek, Solano, Carlos, Nicholson, Emma, Yueksel, Meltem Kurt, Carlson, Kristina, Aguado, Beatriz, Besley, Caroline, Byrne, Jenny, Heras, Immaculada, Dignan, Fiona, Kroeger, Nicolaus, Robin, Christine, Khan, Anjum, Lenhoff, Stig, Grassi, Anna, Dobsinska, Veronika, Miranda, Nuno, Jimenez, Maria-Jose, Yonal-Hindilerden, Ipek, Wilson, Keith, Averbuch, Dina, Cesaro, Simone, Xhaard, Alienor, Knelange, Nina, Styczynski, Jan, Mikulska, Malgorzata, de la Camara, Rafael, Ljungman, Per, Tridello, Gloria, Pinana, Jose Luis, Ciceri, Fabio, Sengeloev, Henrik, Kulagin, Alexander, Mielke, Stephan, Yegin, Zeynep Arzu, Collin, Matthew, Einardottir, Sigrun, Lepretre, Sophie Ducastelle, Maertens, Johan, Campos, Antonio, Metafuni, Elisabetta, Pichler, Herbert, Folber, Frantisek, Solano, Carlos, Nicholson, Emma, Yueksel, Meltem Kurt, Carlson, Kristina, Aguado, Beatriz, Besley, Caroline, Byrne, Jenny, Heras, Immaculada, Dignan, Fiona, Kroeger, Nicolaus, Robin, Christine, Khan, Anjum, Lenhoff, Stig, Grassi, Anna, Dobsinska, Veronika, Miranda, Nuno, Jimenez, Maria-Jose, Yonal-Hindilerden, Ipek, Wilson, Keith, Averbuch, Dina, Cesaro, Simone, Xhaard, Alienor, Knelange, Nina, Styczynski, Jan, Mikulska, Malgorzata, and de la Camara, Rafael

Abstract

Introduction: COVID-19 has been associated with high morbidity and mortality in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. Methods: This study reports on 986 patients reported to the EBMT registry during the first 29 months of the pandemic. Results: The median age was 50.3 years (min - max; 1.0 - 80.7). The median time from most recent HCT to diagnosis of COVID-19 was 20 months (min - max; 0.0 - 383.9). The median time was 19.3 (0.0 - 287.6) months during 2020, 21.2 (0.1 - 324.5) months during 2021, and 19.7 (0.1 - 383.9) months during 2022 (p = NS). 145/986 (14.7%) patients died; 124 (12.6%) due to COVID-19 and 21 of other causes. Only 2/204 (1%) fully vaccinated patients died from COVID-19. There was a successive improvement in overall survival over time. In multivariate analysis, increasing age (p<.0001), worse performance status (p<.0001), contracting COVID-19 within the first 30 days (p<.0001) or 30 - 100 days after HCT (p=.003), ongoing immunosuppression (p=.004), pre-existing lung disease (p=.003), and recipient CMV seropositivity (p=.004) had negative impact on overall survival while patients contracting COVID-19 in 2020 (p<.0001) or 2021 (p=.027) had worse overall survival than patients with COVID-19 diagnosed in 2022. Discussion: Although the outcome of COVID-19 has improved, patients having risk factors were still at risk for severe COVID-19 including death.

Published
2023
Full Text
View/download PDF

26. Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?

Author

Solano de la Asunción, Carlos, Hernani, Rafael, Albert, Eliseo, Gómez, María Dolores, Giménez, Estela, Benzaquén, Ana, González-Barberá, Eva María, Hernández-Boluda, Juan Carlos, Pérez, Ariadna, Piñana, José Luis, Chorao, Pedro, Guerreiro, Manuel, Montoro, Juan, Sanz, Jaime, Solano, Carlos, and Navarro, David

Published
2023
Full Text
View/download PDF

27. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation

Author

Barba, Pere, Martino, Rodrigo, Pérez-Simón, José Antonio, Fernández-Avilés, Francesc, Castillo, Nerea, Piñana, José Luis, López-Anglada, Lucía, Rovira, Montserrat, Bosch, Francesc, Carreras, Enric, Corral, Lucía López, Sierra, Jorge, and Valcárcel, David

Published
2014
Full Text
View/download PDF

31. Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

Author

Gutierrez, Antonio, Bento, Leyre, Novelli, Silvana, Martin, Alejandro, Gutierrez, Gonzalo, Queralt Salas, Maria, Bastos-Oreiro, Mariana, Perez, Ariadna, Hernani, Rafael, Cruz Viguria, Maria, Lopez-Godino, Oriana, Montoro, Juan, Pinana, Jose Luis, Ferra, Christelle, Parody, Rocio, Martin, Carmen, Espanol, Ignacio, Yanez, Lucrecia, Rodriguez, Guillermo, Zanabili, Joud, Herrera, Pilar, Varela, Maria Rosario, Sampol, Antonia, Solano, Carlos, Caballero, Dolores, On Behalf Of The Grupo Espanol de Trasplante de Progenitores, Hematopoyeticos Geth And Grupo Espanol de Linfoma Y Trasplante Autologo, and Geltamo

Subjects
CAR-T cell therapy, graft-versus-lymphoma effect, non-relapse mortality, target therapy, acute graft-versus-host disease, allogeneic stem-cell transplantation, mantle cell lymphoma
Abstract

Allo-SCT is a curative option for selected patients with relapsed/refractory (R/R) MCL, but with significant NRM. We present the long-term results of patients receiving allo-SCT in Spain from March 1995 to February 2020. The primary endpoints were EFS, OS, and cumulative incidence (CI) of NRM, relapse, and GVHD. We included 135 patients, most (85%) receiving RIC. After a median follow-up of 68 months, 5-year EFS and OS were 47 and 50%, respectively. Overall and CR rates were 86 and 80%. The CI of relapse at 1 and 3 years were 7 and 12%. NRM at day 100 and 1 year were 17 and 32%. Previous ASCT and Grade 3-4 aGVHD were associated with a higher NRM. Grade 3-4 aGVHD, donor type (mismatch non-related), and the time-period 2006-2020 were independently related to worse EFS. Patients from 1995-2005 were younger, most from HLA-identical sibling donors, and were pretreated less. Our data confirmed that allo-SCT may be a curative option in R/R MCL with low a CI of relapse, although NRM is still high, being mainly secondary to aGVHD. The arrival of new, highly effective and low toxic immunotherapeutic or targeted therapies inevitably will relegate allo-SCT to those fit patients who fail these therapies, far away from the optimal timing of treatment.

Published
2022

36. Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain

Author

Boluda, Blanca, Solana-Altabella, Antonio, Cano, Isafer, Acuna-Cruz, Evelyn, Rodriguez-Veiga, Rebeca, Ballesta-Lopez, Octavio, Megias-Vericat, Juan Eduardo, Martinez-Cuadron, David, Gomez, Ines, Solves, Pila, Lorenzo, Indignacio, Pinana, Jose Luis, Sanz, Jaime, Guerreiro, Manuel, Montoro Gomez, Juan, Diaz-Gonzalez, Alvaro, Marco, Javier, Blanco, Ana, Sanz, Miguel A, and Montesinos, Pau

Subjects
host disease, fluids and secretions, cost comparison, extracorporeal photopheresis, education, graft&#8208, vs&#8208, healthcare resource utilization
Abstract

Background This study assessed pharmacoeconomic costs associated with extracorporeal photopheresis (ECP) compared with other available second-line therapies for chronic graft-vs-host disease (cGvHD) in a tertiary Spanish institution. Methods Patients (>= 18 years) diagnosed with steroid-refractory cGvHD were eligible. Data were collected retrospectively from index date until 1 year or relapse. Patients were distributed in two cohorts (ECP vs non-ECP), matched by age ( 40), hematopoietic stem cell transplant (HLA-identical sibling donor or other) and number of previous immunosuppressive lines (1, 2, or >= 3). Costs were assigned using the 2016 diagnosis-related group (DRG) system: DRG 579 (euro22 383) overnight stay due to major complication (ie, sepsis, pneumonia, parenteral nutrition, or respiratory failure), and DRG 875 (euro5154) if no major complication. The primary endpoint was healthcare resource utilization per patient. Results Forty patients (n = 20 per cohort) were included. Median age was 49, and 37.5% were female. Mean total cost per patient was euro25 319 (95% CI: euro17 049-euro33 590) across the two cohorts, with a slightly lower mean cost per ECP-treated patient (euro23 120) compared with the non-ECP cohort (euro27 519; P = .597). Twenty-seven inpatient hospitalizations occurred among ECP-treated patients, vs 33 in the non-ECP cohort. Day hospital and external consultations were more frequent in the ECP cohort. However, fewer inpatient admissions included DRG 579 compared with the non-ECP cohort (44% vs 58%). Inpatient length of stay was slightly shorter in the ECP cohort (30 vs 49 days; P = .298). Conclusions ECP treatment may yield economic savings in Spain through resource savings and moving costs toward outpatient care.

Published
2021

37. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Author

Pinana, Jose Luis, Xhaard, Alienor, Tridello, Gloria, Passweg, Jakob, Kozijn, Anne, Polverelli, Nicola, Blijlevens, N.M., Camara, Rafael de la, Styczynski, Jan, Pinana, Jose Luis, Xhaard, Alienor, Tridello, Gloria, Passweg, Jakob, Kozijn, Anne, Polverelli, Nicola, Blijlevens, N.M., Camara, Rafael de la, and Styczynski, Jan

Abstract

Item does not contain fulltext

Published
2021

39. Clinical Validation of the Myelofibrosis Transplant Scoring System in an Independent Series of Myelofibrosis Patients Undergoing Allogeneic Hematopoietic Transplantation

Author

Correa, Juan-Gonzalo, primary, de la Puerta, Rosalía, additional, Benzaquen, Ana, additional, Mora, Jorge, additional, Martín, Ana A., additional, Dorado, Nieves, additional, Fox, María Laura, additional, Saez-Martin, Adolfo, additional, Rovira, Montserrat, additional, Mora Castera, Elvira, additional, Hernani, Rafael, additional, Esquirol, Albert, additional, Gómez-Centurión, Ignacio, additional, Aguilar-Perea, Veronica, additional, Garcia Gutierrez, Valentin, additional, Osorio-Prendes, Santiago, additional, Sanchez-Guijo, Fermin, additional, García-Cadenas, Irene, additional, Pinana, Jose Luis, additional, Alvarez-Larrán, Alberto, additional, Martino, Rodrigo, additional, Solano, Carlos, additional, Cervantes, Francisco, additional, and Hernandez Boluda, Juan Carlos, additional

Published
2019
Full Text
View/download PDF

40. Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study

Author

Vago, Luca, primary, Toffalori, Cristina, additional, Ahci, Müberra, additional, Lange, Vinzenz, additional, Lang, Kathrin, additional, Todaro, Sonia, additional, Lorentino, Francesca, additional, Stempelmann, Karin, additional, Heinold, Andreas, additional, Stoelzel, Friedrich, additional, Waterhouse, Miguel, additional, Claus, Rainer, additional, Gendzekhadze, Ketevan, additional, Onozawa, Masahiro, additional, Devillier, Raynier, additional, Tang, Ruoping, additional, Ulman, Maayan, additional, Kwon, Mi, additional, Gojo, Ivana, additional, Ruggeri, Loredana, additional, Imovilli, Annalisa, additional, Facchini, Luca, additional, Lazarevic, Dejan, additional, Lupo Stanghellini, Maria Teresa, additional, Peccatori, Jacopo, additional, Steckel, Nina Kristin, additional, Horn, Peter A., additional, Picardi, Alessandra, additional, Manetta, Sara, additional, Busca, Alessandro, additional, Pinana, Jose Luis, additional, Sanz, Jaime, additional, Martínez-Laperche, Carolina, additional, Ciurea, Stefan O., additional, Luznik, Leo, additional, Velardi, Andrea, additional, Arcese, William, additional, Sanz, Guillermo, additional, Pini, Massimo, additional, Bruno, Benedetto, additional, Kobbe, Guido, additional, Al Malki, Monzr, additional, Teshima, Takanori, additional, Kroeger, Nicolaus, additional, Finke, Jürgen, additional, Nagler, Arnon, additional, Blaise, Didier, additional, Mohty, Mohamad, additional, Bornhäuser, Martin, additional, Beelen, Dietrich W., additional, Schmidt, Alexander H., additional, Ciceri, Fabio, additional, and Fleischhauer, Katharina, additional

Published
2018
Full Text
View/download PDF

41. 138 - Comparison of Single Unmanipulated Umbilical Cord Blood or Co-Infusion of an Umbilical Cord Blood Graft with CD34+ Cells From a Third Party Donor in Adults with Acute Leukemia

Author

Sanz, Jaime, Kwon, Mi, Bautista, Guiomar, Sanz, Miguel A., Balsalobre, Pascual, Piñana, José Luis, Solano, Carlos, Duarte, Rafael F., Ferrá, Christelle, Martín, Carmen, Barba, Pere, Pascual, Maria Jesús, Martino, Rodrigo, Gayoso, Jorge, Regidor, Carmen, de la Iglesia, Almudena, Montoro, Juan, Diez-Martin, José Luis, Sanz, Guillermo, and Cabrera, Rafael

Published
2017
Full Text
View/download PDF

42. 402 - A Time-to-Event Model for Acute Renal Failure in Sirolimus and Tacrolimus-Based Graft-Versus-Host Disease Prophylaxis for Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Author

Piñana, José Luis, Perez-Pitarch, Alejandro, Garcia-Cadenas, Irene, Barba, Pere, Hernandez-Boluda, Juan-Carlos, Fox, Maria Laura, Terol, Maria José, Queraltó, Josep Maria, Vima, Jaume, Valcarcel, David, Ferriols-Lisart, Rafael, Sierra, Jorge, Martino, Rodrigo, and Solano, Carlos

Published
2017
Full Text
View/download PDF

43. The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Author

Barba, Pere, primary, Valcarcel, David, additional, López-Corral, Lucía, additional, fernandez-Aviles, Francesc, additional, Martino, Rodrigo, additional, Cabrero, Monica, additional, Rovira, Montserrat, additional, Pinana, jose Luis, additional, Brunet, Salut, additional, Carreras, Enric, additional, Caballero, maria Dolores, additional, and Sierra, Jorge, additional

Published
2012
Full Text
View/download PDF

45. An International Multicenter Comparative Analysis of Tacrolimus Plus Sirolimus with or without Antithymocyte Globulin As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Allogeneic Hematopoietic Cell Transplantation

Author

Kharfan-Dabaja, Mohamed A., Parody, Rocio, Perkins, Janelle, Lopez-Godino, Oriana, Lopez-Corral, Lucia, Vazquez, Lourdes, Caballero, Dolores, Falantes, Jose, Shapiro, Jamie, Orti, Guillermo, Barba, Pere, Valcárcel, David, Esquirol, Alber, Martino, Rodrigo, Piñana, Jose Luis, Solano, Carlos, Pidala, Joseph A, Anasetti, Claudio, and Perez-Simon, Jose A.

Published
2015
Full Text
View/download PDF

46. Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Author

Bastos-Oreiro, Mariana, Balsalobre, Pascual, Champ, Diana, Churruca, Juan, Pascual, Maria Jesus, Herrera, Pilar, Bento, Leyre, Piñana, Jose Luis, Jimenez, Santiago, Humala, Karem, Montesinos, Pau, Heras, Inmaculada, Iglesias, Almudena, Perez-Corral, Ana, Pascual, Cristina, Martinez-Laperche, Carolina, Kwon, Mi, Gayoso, Jorge, and Diez-Martin, Jose L.

Published
2015
Full Text
View/download PDF

47. Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Author

Garcia-Sanz, Ramon, Sureda, Anna, Alonso-Alvarez, Sara, Gonzalez, Ana Pilar, Rodriguez, Antonia, Salar, Antonio, de la Cruz, Fatima, Domingo, Eva, Moreno, Miriam, Lopez, Javier, Sr., Piñana, Jose Luis, Rodriguez, Gabriela, Canales, Miguel, Gurierrez, Antonio Manuel, López-Guillermo, Armando, Caballero, María Dolores, Jimenez, Silvia, and Martinez, Carmen

Published
2015
Full Text
View/download PDF

48. Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results

Author

Gayoso, Jorge, Balsalobre, Pascual, Kwon, Mi, Castilla-Llorente, Cristina, Pascual, Maria Jesús, López-Corral, Lucía, Piñana, José Luis, Bermúdez, Arancha, Pérez-Simón, José Antonio, Herrera, Pilar, Montesinos, Pau, Ferrá, Christelle, Sampol, Antonia, Anguita, Javier, Heras, Inmaculada, Champ, Diana, Martínez-Laperche, Carolina, Solano, Carlos, Caballero, Dolores, and Diez-Martin, José Luis

Published
2015
Full Text
View/download PDF

49. Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Busulfan (BUX) Based Reduced Intensity Conditioning (RIC) Regimens and Post-Transplant Cyclophosphamide (PT-CY) as GVHD Prophylaxis in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL)

Author

Gayoso, Jorge, Balsalobre, Pascual, Pascual, Maria Jesús, Castilla-Llorente, Cristina, Caballero, Dolores, Kwon, Mi, Serrano, David, Piñana, José Luis, Herrera, Pilar, Ferrá, Christelle, Pascual, Cristina, Heras, Inmaculada, Montesinos, Pau, Olavarría, Eduardo, Bento, Leyre, Buño, Ismael, and Diez-Martin, José Luis

Published
2015
Full Text
View/download PDF

50. Hepatic Toxicity After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation: Incidence, Characteristics and Risk Factors In a Cohort of 452 Patients.

Author

Barba, Pere, primary, Martino, Rodrigo, additional, Pinana, jose Luis, additional, Perez-Simon, Jose Antonio, additional, fernandez-Aviles, Francesc, additional, Valcarcel, David, additional, Rovira, Montserrat, additional, Lopez-Anglada, Lucia, additional, Novelli, Silvana, additional, Carreras, Enric, additional, and Sierra, Jorge, additional

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results